Reducing rectal injury during external beam radiotherapy for prostate cancer (Q38106626)

29 August 2017

Reducing rectal injury during external beam radiotherapy for prostate cancer (English)

1 reference

29 August 2017

1 reference

Tiziana Rancati

2

0 references

Riccardo Valdagni

object named as

Riccardo Valdagni

series ordinal

1

0 references

language of work or name

English

0 references

publication date

14 May 2013

1 reference

29 August 2017

Nature Reviews Urology

1 reference

29 August 2017

10

1 reference

29 August 2017

345-357

1 reference

29 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2013.96

29 August 2017

0 references

cites work

Recent advances in radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Intensity-modulated radiotherapy in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Human Collagen Injections to Reduce Rectal Dose During Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Is there a role for endorectal balloons in prostate radiotherapy? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Topical butyrate for acute radiation proctitis: randomised, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Anorectal function evaluation and predictive factors for faecal incontinence in 600 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Longitudinal study of intestinal symptoms and fecal continence in patients with conformal radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

A comparison of dose–volume constraints derived using peak and longitudinal definitions of late rectal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Radiation dose-volume effects in radiation-induced rectal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Dose-volume effects for normal tissues in external radiotherapy: pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Modeling the effects of inhomogeneous dose distributions in normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Organizational response of normal tissues to irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Late rectal bleeding after 3D-CRT for prostate cancer: development of a neural-network-based predictive model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Deformable registration of the planning image (kVCT) and the daily images (MVCT) for adaptive radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Daily isocenter correction with electromagnetic-based localization improves target coverage and rectal sparing during prostate radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Anatomy of Denonvilliers' fascia and pelvic nerves, impotence, and implications for the colorectal surgeon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Effects of prostate-rectum separation on rectal dose from external beam radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Biodegradable inflatable balloon for reducing radiation adverse effects in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Short chain fatty acids relax isolated resistance arteries from the human ileum by a mechanism dependent on anion-exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Target motion variability and on-line positioning accuracy during external-beam radiation therapy of prostate cancer with an endorectal balloon device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Is there more than one late radiation proctitis syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: Results of a large multicenter observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Late Fecal Incontinence After High-Dose Radiotherapy for Prostate Cancer: Better Prediction Using Longitudinal Definitions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Is It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

LENT SOMA scales for all anatomic sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Dose-Response Relations for Anal Sphincter Regarding Fecal Leakage and Blood or Phlegm in Stools after Radiotherapy for Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

On-line correction of beam portals in the treatment of prostate cancer using an endorectal balloon device

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Invasion of Denonvilliers' fascia in radical prostatectomy specimens.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Predictors for Rectal and Intestinal Acute Toxicities During Prostate Cancer High-Dose 3D-CRT: Results of a Prospective Multicenter Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

A practical method to achieve prostate gland immobilization and target verification for daily treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Prostate immobilization using a rectal balloon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Real-Time Study of Prostate Intrafraction Motion During External Beam Radiotherapy With Daily Endorectal Balloon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

A Study to Quantify the Effectiveness of Daily Endorectal Balloon for Prostate Intrafraction Motion Management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

An endorectal balloon reduces intrafraction prostate motion during radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.96

Effect of volatile fatty acids on blood flow and oxygen uptake by the dog colon.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23670182

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRUROL.2013.96

1 reference

PubMed ID

23670182

Dimensions Publication ID

29 August 2017

1030816425

0 references

Fatcat ID

release_bjm4y47qnfe3xhk6lvx33lr3v4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bjm4y47qnfe3xhk6lvx33lr3v4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

23670182

1 reference

PubMed ID

23670182